<PAPER><mode2 name='PMC3379731' hasDoc='yes' version='597'></mode2><article xmlns:mml='http://www.w3.org/1998/Math/MathML' xmlns:xlink='http://www.w3.org/1999/xlink' article-type='research-article'><front><journal-meta><journal-id journal-id-type='nlm-ta'>Dement Geriatr Cogn Dis Extra</journal-id><journal-id journal-id-type='iso-abbrev'>Dement Geriatr Cogn Dis Extra</journal-id><journal-id journal-id-type='publisher-id'>DEE</journal-id><journal-title-group><journal-title>Dementia and Geriatric Cognitive Disorders EXTRA</journal-title></journal-title-group><issn pub-type='epub'>1664-5464</issn><publisher><publisher-name>S. Karger AG</publisher-name><publisher-loc>Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type='pmcid'>3379731</article-id><article-id pub-id-type='doi'>10.1159/000338231</article-id><article-id pub-id-type='publisher-id'>dee-0002-0209</article-id><article-categories><subj-group subj-group-type='heading'><subject>Original Research Article</subject></subj-group></article-categories><title-group><article-title><s sid='1'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1><CoreSc2 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc2>Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer's Disease: Kuopio ALSOVA Study</s></article-title></title-group><contrib-group><contrib contrib-type='author'><name><surname>Hallikainen</surname><given-names>Ilona</given-names></name><xref rid='aff1' ref-type='aff'><sup>a</sup></xref></contrib><contrib contrib-type='author'><name><surname>Koivisto</surname><given-names>Anne M.</given-names></name><xref rid='aff1' ref-type='aff'><sup>a</sup></xref><xref rid='aff4' ref-type='aff'><sup>d</sup></xref></contrib><contrib contrib-type='author'><name><surname>Paajanen</surname><given-names>Teemu</given-names></name><xref rid='aff1' ref-type='aff'><sup>a</sup></xref></contrib><contrib contrib-type='author'><name><surname>Hiltunen</surname><given-names>Asta</given-names></name><xref rid='aff6' ref-type='aff'><sup>f</sup></xref></contrib><contrib contrib-type='author'><name><surname>Karppi</surname><given-names>Pertti</given-names></name><xref rid='aff7' ref-type='aff'><sup>g</sup></xref></contrib><contrib contrib-type='author'><name><surname>Vanhanen</surname><given-names>Matti</given-names></name><xref rid='aff5' ref-type='aff'><sup>e</sup></xref></contrib><contrib contrib-type='author'><name><surname>Välimäki</surname><given-names>Tarja</given-names></name><xref rid='aff2' ref-type='aff'><sup>b</sup></xref><xref rid='aff3' ref-type='aff'><sup>c</sup></xref></contrib><contrib contrib-type='author'><name><surname>Herukka</surname><given-names>Sanna-Kaisa</given-names></name><xref rid='aff1' ref-type='aff'><sup>a</sup></xref><xref rid='aff4' ref-type='aff'><sup>d</sup></xref></contrib><contrib contrib-type='author'><name><surname>Soininen</surname><given-names>Hilkka</given-names></name><xref rid='aff1' ref-type='aff'><sup>a</sup></xref><xref rid='aff4' ref-type='aff'><sup>d</sup></xref></contrib><contrib contrib-type='author'><name><surname>Hänninen</surname><given-names>Tuomo</given-names></name><xref rid='aff4' ref-type='aff'><sup>d</sup></xref><xref rid='cor1' ref-type='corresp'>*</xref></contrib></contrib-group><aff id='aff1'><sup>a</sup>Institute of Clinical Medicine, Neurology, University of Eastern Finland, Mikkeli, Finland</aff><aff id='aff2'><sup>b</sup>Department of Nursing Science, University of Eastern Finland, Mikkeli, Finland</aff><aff id='aff3'><sup>c</sup>Finnish Doctoral Program in Nursing Science, University of Eastern Finland, Mikkeli, Finland</aff><aff id='aff4'><sup>d</sup>Department of Neurology, Kuopio University Hospital, Mikkeli, Finland</aff><aff id='aff5'><sup>e</sup>Niuvanniemi Hospital, Kuopio, Mikkeli, Finland</aff><aff id='aff6'><sup>f</sup>Department of Neurology, North Karelia Central Hospital, Joensuu, Mikkeli, Finland</aff><aff id='aff7'><sup>g</sup>Mikkeli Central Hospital, Mikkeli, Finland</aff><author-notes><corresp id='cor1'>*Tuomo Hänninen, Department of Neurology, Kuopio University Hospital, FI–70210 Kuopio (Finland), Tel. +358 17 173 037, E-Mail <email>tuomo.hanninen@kuh.fi</email></corresp></author-notes><pub-date pub-type='collection'><season>Jan-Dec</season><year>2012</year></pub-date><pub-date pub-type='epub'><day>5</day><month>5</month><year>2012</year></pub-date><pub-date pub-type='pmc-release'><day>5</day><month>5</month><year>2012</year></pub-date><volume>2</volume><issue>1</issue><fpage>209</fpage><lpage>218</lpage><permissions><copyright-statement>Copyright © 2012 by S. Karger AG, Basel</copyright-statement><copyright-year>2012</copyright-year><license license-type='open-access' xlink:href='http://creativecommons.org/licenses/by-nc-nd/3.0/'><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (<ext-link ext-link-type='uri' xlink:href='http://creativecommons.org/licenses/by-nc-nd/3.0/'>http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link>). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on <ext-link ext-link-type='uri' xlink:href='http://www.karger.com'>http://www.karger.com</ext-link> and the terms of this license are included in any shared versions.</license-p></license></permissions><abstract><sec><title>Background/Aim</title><p><s sid='2'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Alzheimer's disease (AD) causes impairment in memory and other cognitive functions as well as neuropsychiatric symptoms and limitations in the activities of daily living (ADL).</s><s sid='3'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1> The aim of this study was to examine whether demographic variables, dementia severity, ADL and neuropsychiatric symptoms are associated with cognition in very mild or mild AD.</s></p></sec><sec><title>Methods</title><p><s sid='4'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>We analyzed the baseline data of 236 patients with very mild or mild AD participating in a prospective AD follow-up study (ALSOVA).</s><s sid='5'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The Consortium to Establish a Registry for Alzheimer's Disease neuropsychological battery total score was used in the evaluation of the global cognitive performance.</s></p></sec><sec><title>Results</title><p><s sid='6'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1>Cognition was associated with dementia severity and ADL but not with neuropsychiatric symptoms.</s><s sid='7'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> ADL functions were associated with both cognitive performance and neuropsychiatric symptoms.</s></p></sec><sec><title>Conclusion</title><p><s sid='8'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>Even patients with very mild or mild AD may exhibit neuropsychiatric symptoms not related to cognitive impairment.</s><s sid='9'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> The results of this study emphasize the importance of taking a multidimensional approach to the diagnostic and prognostic evaluation of AD patients already in the early stages of the disease.</s></p></sec></abstract><kwd-group><title>Key Words</title><kwd>Alzheimer's disease</kwd><kwd>Dementia</kwd><kwd>Memory</kwd><kwd>Neuropsychiatric symptoms</kwd><kwd>Neuropsychological tests</kwd></kwd-group><counts><table-count count='2'></table-count><ref-count count='38'></ref-count><page-count count='10'></page-count></counts></article-meta></front><body><sec id='sec1_1'><title>Introduction</title><p><s sid='10'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Alzheimer's disease (AD) is a progressive neurodegenerative disease which is characterized by impairment in cognitive and functional abilities as well as by neuropsychiatric symptoms.</s><s sid='11'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Cognitive impairment can include impairment in memory, visuospatial functions, language and executive functions.</s><s sid='12'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> In addition, neuropsychiatric symptoms, such as depression, apathy and agitation, seem to be common already in early stages of AD and can have an impact on both patients’ and care-givers’ well-being [<xref rid='B1' ref-type='bibr'>1</xref>, <xref rid='B2' ref-type='bibr'>2</xref>, <xref rid='B3' ref-type='bibr'>3</xref>].</s><s sid='13'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Cognitive performance has been consistently associated with functional ability [<xref rid='B4' ref-type='bibr'>4</xref>, <xref rid='B5' ref-type='bibr'>5</xref>, <xref rid='B6' ref-type='bibr'>6</xref>, <xref rid='B7' ref-type='bibr'>7</xref>, <xref rid='B8' ref-type='bibr'>8</xref>]; however, the association of neuropsychiatric symptoms with cognition and daily functioning is unclear [<xref rid='B7' ref-type='bibr'>7</xref>, <xref rid='B9' ref-type='bibr'>9</xref>, <xref rid='B10' ref-type='bibr'>10</xref>, <xref rid='B11' ref-type='bibr'>11</xref>, <xref rid='B12' ref-type='bibr'>12</xref>, <xref rid='B13' ref-type='bibr'>13</xref>], in spite of the fact that the amount of neuropsychiatric symptoms seems to increase in patients with more advanced dementia [<xref rid='B14' ref-type='bibr'>14</xref>, <xref rid='B15' ref-type='bibr'>15</xref>].</s><s sid='14'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Thus, more information is needed to elucidate how these features of AD are interrelated.</s></p><p><s sid='15'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>The Consortium to Establish a Registry for Alzheimer's Disease neuropsychological battery (CERAD-NB) [<xref rid='B16' ref-type='bibr'>16</xref>] is a widely used, short and reliable measure of cognitive impairment in AD patients [<xref rid='B17' ref-type='bibr'>17</xref>, <xref rid='B18' ref-type='bibr'>18</xref>].</s><s sid='16'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The method for calculating a total score for the CERAD-NB was published in 2005 [<xref rid='B19' ref-type='bibr'>19</xref>], and recent studies have supported both the validity and usefulness of the CERAD total score for the detection of mild cognitive impairment and dementia [<xref rid='B20' ref-type='bibr'>20</xref>, <xref rid='B21' ref-type='bibr'>21</xref>, <xref rid='B22' ref-type='bibr'>22</xref>] as well as for monitoring progression of AD dementia [<xref rid='B21' ref-type='bibr'>21</xref>].</s><s sid='17'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> That is, it seems to be more valuable to use the total score than relying on single subtests.</s><s sid='18'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Though the Mini-Mental State Examination (MMSE) [<xref rid='B23' ref-type='bibr'>23</xref>] has been commonly used, it has been claimed to be of limited value as a screening instrument [<xref rid='B24' ref-type='bibr'>24</xref>, <xref rid='B25' ref-type='bibr'>25</xref>] and in measuring progression of AD [<xref rid='B26' ref-type='bibr'>26</xref>].</s></p><p><s sid='19'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1>The present study was designed to examine whether global cognitive performance assessed by the CERAD total score is associated with dementia severity, activities of daily living (ADL) and neuropsychiatric symptoms in patients with very mild or mild AD.</s></p></sec><sec sec-type='methods' id='sec1_2'><title>Methods</title><sec id='sec2_1'><title>Subjects</title><p><s sid='20'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>A total of 241 patients with recently diagnosed very mild or mild AD participated in a prospective AD follow-up study (ALSOVA).</s><s sid='21'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The total follow-up period will be up to 5 years [<xref rid='B1' ref-type='bibr'>1</xref>, <xref rid='B2' ref-type='bibr'>2</xref>].</s><s sid='22'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1> The aim of the ALSOVA study is to elucidate the effects and cost-efficiency of psychosocial rehabilitation.</s><s sid='23'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> The study subjects were recruited from April 2002 to September 2006 from the neurology departments of the University Hospital of Kuopio and North-Karelia Central Hospital and from the geriatric memory clinic of the Central Hospital of Central-Finland.</s></p><p><s sid='24'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>The patients were diagnosed at neurology departments or geriatric memory clinics according to clinical practice, and the diagnosis of AD according to NINCDS-ADRDA guidelines [<xref rid='B27' ref-type='bibr'>27</xref>] was verified by the research doctor.</s><s sid='25'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The baseline data were not used as part of the diagnostic procedure, but it is possible that same methods (e.g. CERAD) have been used.</s><s sid='26'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> All subjects had very mild or mild dementia at baseline.</s><s sid='27'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> Finnish speaking, community-dwelling individuals who were free of comorbid conditions that could have affected cognition and who had a loved one as their caregiver were included.</s></p><p><s sid='28'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>Three subjects from the original study population of 241 subjects were excluded since they were found to have moderate AD, one subject had a diagnosis of Parkinson's disease and another one suffered from blindness.</s><s sid='29'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> Ultimately, 236 patients fulfilled the inclusion criteria for this part of the study.</s></p></sec><sec id='sec2_2'><title>Measures</title><p><s sid='30'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>The extensive data collected included age, gender, education, physical health, medication, household composition, living arrangements, general well-being, caregiver burden, depression, quality of life and society resource utilization [<xref rid='B1' ref-type='bibr'>1</xref>, <xref rid='B2' ref-type='bibr'>2</xref>].</s></p><p><s sid='31'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>The cognitive evaluation was performed with the CERAD-NB [<xref rid='B16' ref-type='bibr'>16</xref>] and MMSE [<xref rid='B23' ref-type='bibr'>23</xref>].</s><s sid='32'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The Finnish version of the CERAD-NB [<xref rid='B28' ref-type='bibr'>28</xref>] consists of nine subtests; the Delayed Recall of Constructional Praxis and the Clock Drawing Test are additions to the original test battery.</s><s sid='33'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> The total score for the CERAD-NB was calculated for each participant according to the subtest addition method [<xref rid='B19' ref-type='bibr'>19</xref>].</s><s sid='34'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The total score was obtained by summing the raw scores from the six subtests (Verbal Fluency Test, modified Boston Naming Test, Word List Memory, Word List Recall, Word List Recognition Discriminability and Constructional Praxis) into a total score (maximum 100 points) according to the original method.</s></p><p><s sid='35'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>The Clinical Dementia Rating (CDR) scale is a rating scale for evaluating the severity of the memory disorder [<xref rid='B29' ref-type='bibr'>29</xref>, <xref rid='B30' ref-type='bibr'>30</xref>].</s><s sid='36'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The structured interview protocol includes six areas, and the scores in each of these sections are combined to obtain a composite score and a sum of boxes (SOB) score.</s><s sid='37'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The Alzheimer's Disease Cooperative Study – Activities of Daily Living Inventory (ADCS-ADL) is a set of informant-based items describing performance of ADL for patients with AD [<xref rid='B4' ref-type='bibr'>4</xref>].</s><s sid='38'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The Neuropsychiatric Inventory (NPI) is an informant-based interview that assesses twelve behavioral disturbances occurring in dementia patients [<xref rid='B31' ref-type='bibr'>31</xref>].</s><s sid='39'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The total NPI score is the sum of the subscale scores (frequency × severity).</s><s sid='40'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Higher scores indicate more behavioral disturbance.</s></p><p><s sid='41'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Data were missing for one subject for Constructional Praxis, Delayed Constructional Praxis and Clock Drawing Test because of problems in vision and for another subject for the Word List Recognition because of difficulties understanding the test instructions.</s><s sid='42'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Exp1' type='Exp'></CoreSc1> Thus, the data for the CERAD total score were missing for two subjects.</s></p></sec><sec id='sec2_3'><title>Ethical Considerations</title><p><s sid='43'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>The Ethics Committee of Kuopio University Hospital approved the ALSOVA study protocol.</s><s sid='44'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The study participants were recruited from three memory clinics serving three hospital districts.</s><s sid='45'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Potential participants received written and oral information of the study, and an initial visit was arranged soon after the diagnosis for those who consented to participate.</s><s sid='46'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The voluntary nature of participation and the confidentiality of data collected were emphasized.</s><s sid='47'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The informed consent form was signed by both the patients with AD and their caregivers.</s><s sid='48'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> The caregivers also provided proxy consent on behalf of the individuals with AD.</s></p></sec><sec id='sec2_4'><title>Data Analysis</title><p><s sid='49'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Descriptive statistics were used to summarize the variables studied and the characteristics of the participants.</s><s sid='50'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The data were analyzed with SPSS for Windows 14.0 software package.</s><s sid='51'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The t test was used to compare cognition and severity of dementia and the Mann-Whitey U test to compare ADL and neuropsychiatric symptoms between men and women and between CDR 0.5 and 1 groups.</s><s sid='52'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Pearson's correlation was used to analyze relations between the CERAD-NB, MMSE, CDR-SOB, age and education.</s><s sid='53'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Spearman's correlation was used to analyze the ADCS-ADL or NPI scores.</s><s sid='54'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> A p value &lt;0.05 was considered statistically significant.</s></p></sec></sec><sec sec-type='results' id='sec1_3'><title>Results</title><p><s sid='55'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1>Almost half of the study participants (n = 115, 48.7%) were men.</s><s sid='56'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> Most of the patients (66.1%) had mild dementia (CDR = 1) and 33.9% had very mild dementia (CDR = 0.5).</s><s sid='57'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> In 70.3% of cases, the caregiver was a spouse, whereas in 23.7% of cases, the caregiver was a child.</s><s sid='58'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obj1' type='Obj'></CoreSc1> The remaining 6% of caregivers were siblings or children's spouses.</s><s sid='59'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> On average, the participants were recruited 5 months after diagnosis.</s><s sid='60'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Almost all patients (96.2%) were on AD medication, with 93.8% of them using acetylcholine esterase inhibitors and 6.2% using memantine.</s><s sid='61'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Table <xref rid='T1' ref-type='table'>1</xref> shows the mean age, education in years, CDR-SOB score, CERAD total score, MMSE score, ADCS-ADL score and NPI total score.</s><s sid='62'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Only 18.2% of the participants had no neuropsychiatric symptoms, 21.6% had one symptom, 13.1% two and 47.0% displayed symptoms in at least three different NPI domains.</s><s sid='63'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> The most common neuropsychiatric symptoms were apathy (48.3%), depression (36.4%) and irritability (33.9%).</s></p><p><s sid='64'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>There was no significant difference in the CERAD total score, MMSE score, CDR-SOB score or NPI score between men and women.</s><s sid='65'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Women performed better on the ADCS-ADL than men (z = −4.287, p &lt; 0.001).</s><s sid='66'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Not surprisingly, participants with very mild dementia (CDR = 0.5) outperformed those with mild dementia (CDR = 1) on the CERAD total score (t(2,232) = 4.308, p &lt; 0.001) and MMSE score (t(2,234) = 5.886, p &lt; 0.001), received a lower NPI total score (z = −2.892, p = 0.028) and a greater ADCS-ADL score (z = −7.032, p &lt; 0.001; table <xref rid='T1' ref-type='table'>1</xref>).</s><s sid='67'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Table <xref rid='T2' ref-type='table'>2</xref> shows the results of the correlation analyses between age and education and CERAD total, MMSE, CDR-SOB and ADCS-ADL scores.</s><s sid='68'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> The length of education was positively correlated with the CERAD total score and the MMSE score, but there was no significant correlation between age and the CERAD total score or age and the MMSE score.</s><s sid='69'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Age correlated negatively with ADCS-ADL scores, and education correlated negatively with CDR-SOB scores and positively with ADCS-ADL scores.</s><s sid='70'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> NPI scores did not correlate with education or age.</s></p><p><s sid='71'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Table <xref rid='T2' ref-type='table'>2</xref> shows the results of the correlation analyses between the CERAD total, MMSE, CDR-SOB, ADCS-ADL and NPI total scores.</s><s sid='72'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> The CDR-SOB score was negatively correlated with the CERAD total and MMSE scores, whereas the ADCS-ADL score was positively correlated with the CERAD total and MMSE scores.</s><s sid='73'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> We also analyzed the correlation between the CERAD total and ADCS-ADL scores separately for subjects with low education (≤8 years) and subjects with high education (≥9 years).</s><s sid='74'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> The correlation was stronger in the more educated group (r = 0.351, p = 0.009) but was significant also in the low-educated group (r = 0.186, p = 0.013).</s><s sid='75'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> The ADCS-ADL score was negatively correlated with the CDR-SOB score.</s><s sid='76'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> The NPI total score was not correlated with the CERAD total score or the MMSE score.</s><s sid='77'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> We also analyzed the correlation between the CERAD total and NPI scores separately in low-and high-educated groups and got similar results.</s><s sid='78'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> None of the NPI subscales was correlated with the CERAD total score and none of the CERAD subtests was correlated with the NPI total score.</s><s sid='79'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> The NPI total score was positively correlated with CDR-SOB score and negatively with ADCS-ADL scores.</s></p></sec><sec sec-type='discussion' id='sec1_4'><title>Discussion</title><p><s sid='80'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Goa1' type='Goa'></CoreSc1>In this study, we investigated correlations between the CERAD total score, ADL and neuropsychiatric measures in a large group of systematically documented AD patients with very mild or mild dementia.</s><s sid='81'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Almost all of them used medication for AD.</s><s sid='82'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> They all participated in a longitudinal study focusing on the effects and cost-efficiency of early psychosocial rehabilitation.</s><s sid='83'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> There have been very few studies using the CERAD total score to measure cognitive performance in AD patients.</s><s sid='84'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> In our study, CERAD total score correlated with the MMSE.</s><s sid='85'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> As expected, participants with clinical staging of very mild dementia (CDR = 0.5) outperformed those with mild dementia (CDR = 1).</s><s sid='86'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> These findings are consistent with results from previous studies [<xref rid='B19' ref-type='bibr'>19</xref>, <xref rid='B21' ref-type='bibr'>21</xref>, <xref rid='B22' ref-type='bibr'>22</xref>].</s></p><p><s sid='87'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>The influence of education on the results of the CERAD-NB subtests has been noted in many studies, but the influence of age and gender has varied across studies [<xref rid='B17' ref-type='bibr'>17</xref>, <xref rid='B19' ref-type='bibr'>19</xref>, <xref rid='B32' ref-type='bibr'>32</xref>, <xref rid='B33' ref-type='bibr'>33</xref>, <xref rid='B34' ref-type='bibr'>34</xref>, <xref rid='B35' ref-type='bibr'>35</xref>].</s><s sid='88'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Consistent with data on the CERAD subtests for a sample of elderly Finns [<xref rid='B33' ref-type='bibr'>33</xref>], our results in the AD sample revealed a correlation between the CERAD total score and education but not between the CERAD total score and age.</s><s sid='89'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> There was no difference in the CERAD total score between genders.</s><s sid='90'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Our results are in agreement with those of previous studies about the importance of taking into account the educational level of AD patients in any evaluation of cognitive performance conducted with the CERAD-NB.</s></p><p><s sid='91'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1>Although the mean NPI total score is relatively low, it can represent for example several occasional mild symptoms or two weekly moderate symptoms or one severe symptom.</s><s sid='92'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> The mean NPI score in our AD sample is consistent with previous studies with comparable groups of patients [<xref rid='B36' ref-type='bibr'>36</xref>].</s><s sid='93'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> We have previously reported that these symptoms have an impact on both patients’ and care-givers’ well-being already in early stages of AD [<xref rid='B1' ref-type='bibr'>1</xref>, <xref rid='B2' ref-type='bibr'>2</xref>].</s><s sid='94'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Studies in patients with mild cognitive impairment show that neuropsychiatric symptoms may be a predictor of conversion to AD [<xref rid='B37' ref-type='bibr'>37</xref>], which emphasizes the role of evaluation of these symptoms already in the early phase of the disease.</s></p><p><s sid='95'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>There are very few studies where the CERAD total score was used as a measure of cognitive function in the evaluation of associations between cognitive performance, functional ability and neuropsychiatric symptoms.</s><s sid='96'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> In our study, cognition was significantly associated with ADL.</s><s sid='97'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> These results are consistent with those from previous studies conducted with the CERAD total score [<xref rid='B22' ref-type='bibr'>22</xref>] or other cognitive measures [<xref rid='B4' ref-type='bibr'>4</xref>, <xref rid='B5' ref-type='bibr'>5</xref>, <xref rid='B7' ref-type='bibr'>7</xref>, <xref rid='B8' ref-type='bibr'>8</xref>, <xref rid='B9' ref-type='bibr'>9</xref>].</s><s sid='98'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Women received better scores in the ADCS-ADL, which probably reflects the traditional way to share housework in marriages in this generation, and this needs to be taken into account when using ADL measures.</s><s sid='99'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> An association was also detected between ADL and neuropsychiatric symptoms.</s><s sid='100'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> There are many previous findings indicating that neuropsychiatric symptoms are associated with functional limitations [<xref rid='B6' ref-type='bibr'>6</xref>, <xref rid='B7' ref-type='bibr'>7</xref>, <xref rid='B11' ref-type='bibr'>11</xref>, <xref rid='B13' ref-type='bibr'>13</xref>], although some studies have found contrasting results [<xref rid='B5' ref-type='bibr'>5</xref>, <xref rid='B9' ref-type='bibr'>9</xref>].</s></p><p><s sid='101'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1>Most reports in the literature indicate that behavioral symptoms and cognition are not related [<xref rid='B10' ref-type='bibr'>10</xref>, <xref rid='B11' ref-type='bibr'>11</xref>] or that the relationship is weak [<xref rid='B7' ref-type='bibr'>7</xref>, <xref rid='B12' ref-type='bibr'>12</xref>].</s><s sid='102'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> There is also evidence that any change in behavioral symptoms is independent from changes occurring in cognitive measures [<xref rid='B9' ref-type='bibr'>9</xref>].</s><s sid='103'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Instead, Harwood et al. [<xref rid='B6' ref-type='bibr'>6</xref>] described a relationship between psychological and behavioral disturbances and MMSE scores.</s><s sid='104'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Our study, using the CERAD total score and MMSE score, indicates that neuropsychiatric symptoms were not correlated with cognitive performance.</s><s sid='105'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Res1' type='Res'></CoreSc1> Our results are consistent with most of the previous evidence, showing that cognitive and behavioral disturbances are rather distinct entities in AD, at least in the mild stage of the disease.</s><s sid='106'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Obs1' type='Obs'></CoreSc1> Although the correlations between other clinical characteristics (CERAD total, ADCS-ADL, NPI and CDR-SOB scores) were fairly modest (0.23–0.58), they were clearly significant and, on the contrary, the correlations between cognition and neuropsychiatric symptoms did not imply even a tendency of association.</s></p><p><s sid='107'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>There are some limitations to this study.</s><s sid='108'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> All patients and their caregivers voluntarily participated in this 5-year follow-up study and met regularly with the study nurse and psychologist.</s><s sid='109'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Some of the subjects were randomly selected to participate in early psychosocial intervention.</s><s sid='110'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Therefore, this voluntary participation procedure may have produced a selection bias.</s><s sid='111'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Thus, this study population may not completely represent the general population of patients with very mild or mild AD.</s><s sid='112'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Bac1' type='Bac'></CoreSc1> Andersen et al. [<xref rid='B38' ref-type='bibr'>38</xref>] have reported that recruitment from clinical practice and population-based screening represent study samples with different demographic characteristics.</s></p><p><s sid='113'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>Our study population at baseline was homogenous in terms of recently diagnosed very mild or mild AD.</s><s sid='114'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Therefore, results cannot be generalized to patients with more advanced dementia.</s><s sid='115'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> The educational level of older persons in Finland is often lower than in other Western countries, and this needs to be considered when interpreting results.</s><s sid='116'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Despite these limitations, our results strongly support previous studies.</s></p><p><s sid='117'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1>The strength of our study was the use of several different measures and a more extensive cognitive evaluation than the MMSE in a fairly large study population.</s><s sid='118'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> Subsequently, it would be valuable to monitor how cognition, neuropsychiatric symptoms and ADL change with time, and to obtain more information about the usability of the CERAD total score in follow-up studies.</s><s sid='119'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Met1' type='Met'></CoreSc1> This kind of follow-up data could also help to find factors that would predict the progression rate of AD.</s></p><p><s sid='120'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1>In conclusion, we detected that cognitive performance was not associated with neuropsychiatric symptoms, but that ADL were associated with both of these factors.</s><s sid='121'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> It is evident that both the cognitive level and neuropsychiatric symptoms affect the patients’ ability to cope with the demands in everyday life.</s><s sid='122'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Con1' type='Con'></CoreSc1> Our results help to provide information to patients and their caregivers about symptoms during the first years of the disease.</s><s sid='123'><CoreSc1 novelty='None' atype='GSC' advantage='None' conceptID='Mot1' type='Mot'></CoreSc1> Our findings emphasize the need for a multifaceted evaluation of AD symptoms in both the clinical and research setting.</s></p></sec><sec id='sec1_6'><title>Disclosure Statement</title><p>The authors have no conflicts to disclose. The sponsors had neither a role in the analysis or interpretation of these data, nor in the content of the article.</p></sec></body><back><ack><title>Acknowledgements</title><p>This study was supported by grants from the Yrjö-Jahnsson Foundation, Hospital Neuron, Kuopio University Hospital (EVO-grant 5220/5772728) and the Social Insurance Institute of Finland (Kela). The authors gratefully acknowledge the contribution of the late Professor Tuula Pirttilä, project director 2002–2009. The authors also thank study nurse Helena Mäkelä for her invaluable help in organizing and performing the examinations of the study subjects, Vesa Kiviniemi, PhD, for checking statistics and the patients and their caregivers for their time and effort.</p></ack><app-group><app id='app1_1'><title>Appendix: ALSOVA Study Group</title><p>Hilkka Soininen, MD, Professor, project director: Department of Neurology, Kuopio University Hospital and School of Medicine, Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio Campus, Finland.</p><p>Anne Koivisto, PhD, MD, specialist in neurology, study coordinator and principal investigator: Department of Neurology, Kuopio University Hospital and School of Medicine, Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio Campus, Finland.</p><p>Ilona Hallikainen, MPsych, psychologist: Brain Research Unit, Clinical Research Centre, University of Eastern Finland, Kuopio Campus, Finland.</p><p>Sanna-Kaisa Herukka, PhD, researcher: Department of Neurology, Kuopio University Hospital and School of Medicine, Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio Campus, Finland.</p><p>Asta Hiltunen, MD, specialist in neurology: Department of Neurology, North Karelia Central Hospital, Finland.</p><p>Janne Martikainen, PhD, research director: School of Pharmacy, University of Eastern Finland, Kuopio Campus, Finland.</p><p>Helena Mäkelä, study nurse: Brain Research Unit, Clinical Research Centre, University of Eastern Finland, Kuopio Campus, Finland.</p><p>Pertti Karppi, MD, geriatrician: Mikkeli Central Hospital, Finland.</p><p>Kristiina Hongisto, MD, geriatrician: Institute of Public Health and Clinical Nutrition, Department of Geriatrics, University of Eastern Finland, Kuopio Campus, Finland and School of Medicine, Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio Campus, Finland.</p><p>Teemu Paajanen, MPsych, psychologist: Brain Research Unit, Clinical Research Centre, University of Eastern Finland, Kuopio Campus, Finland.</p><p>Anna-Maija Pietilä, PhD, Professor: Department of Nursing Science, University of Eastern Finland, Kuopio Campus, Finland.</p><p>Juhani Sivenius, MD, Professor: Brain Research and Rehabilitation Center Neuron, Department of Neurology, Kuopio University Hospital and School of Medicine, Institute of Clinical Medicine, Neurology, University of Eastern Finland, Kuopio Campus, Finland.</p><p>Hannu Valtonen, PhD, Professor: Department of Health and Social Management, University of Eastern Finland, Kuopio Campus, Finland.</p><p>Matti Vanhanen, PhD, neuropsychologist: Niuvanniemi Hospital, Kuopio, Finland.</p><p>Katri Vehviläinen-Julkunen, Professor: Department of Nursing Science, University of Eastern Finland, Kuopio Campus, Finland.</p><p>Tarja Välimäki, MNSc: Department of Nursing Science, University of Eastern Finland, Kuopio Campus, Finland.</p></app></app-group><ref-list><title>References</title><ref id='B1'><label>1</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Välimäki</surname><given-names>TH</given-names></name><name><surname>Vehviläinen-Julkunen</surname><given-names>KM</given-names></name><name><surname>Pietilä</surname><given-names>AM</given-names></name><name><surname>Pirttilä</surname><given-names>TA</given-names></name></person-group><article-title>Caregiver depression is associated with a low sense of coherence and health-related quality of life</article-title><source>Aging Ment Health</source><year>2009</year><volume>13</volume><fpage>799</fpage><lpage>807</lpage><pub-id pub-id-type='pmid'>19888700</pub-id></element-citation></ref><ref id='B2'><label>2</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Karttunen</surname><given-names>K</given-names></name><name><surname>Karppi</surname><given-names>P</given-names></name><name><surname>Hiltunen</surname><given-names>A</given-names></name><name><surname>Vanhanen</surname><given-names>M</given-names></name><name><surname>Välimäki</surname><given-names>T</given-names></name><name><surname>Martikainen</surname><given-names>J</given-names></name><name><surname>Valtonen</surname><given-names>H</given-names></name><name><surname>Sivenius</surname><given-names>J</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><name><surname>Hartikainen</surname><given-names>S</given-names></name><name><surname>Suhonen</surname><given-names>J</given-names></name><name><surname>Pirttilä</surname><given-names>T</given-names></name><collab>ALSOVA study group</collab></person-group><article-title>Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease</article-title><source>Int J Geriatr Psychiatry</source><year>2011</year><volume>26</volume><fpage>473</fpage><lpage>82</lpage><pub-id pub-id-type='pmid'>21445998</pub-id></element-citation></ref><ref id='B3'><label>3</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Rocca</surname><given-names>P</given-names></name><name><surname>Leotta</surname><given-names>D</given-names></name><name><surname>Liffredo</surname><given-names>C</given-names></name><name><surname>Mingrone</surname><given-names>C</given-names></name><name><surname>Sigaudo</surname><given-names>M</given-names></name><name><surname>Capellero</surname><given-names>B</given-names></name><name><surname>Rocca</surname><given-names>G</given-names></name><name><surname>Simoncini</surname><given-names>M</given-names></name><name><surname>Pirfo</surname><given-names>E</given-names></name><name><surname>Bogetto</surname><given-names>F</given-names></name></person-group><article-title>Neuropsychiatric symptoms underlying caregiver stress and insight in Alzheimer's disease</article-title><source>Dement Geriatr Cogn Disord</source><year>2010</year><volume>30</volume><fpage>57</fpage><lpage>63</lpage><pub-id pub-id-type='pmid'>20689284</pub-id></element-citation></ref><ref id='B4'><label>4</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Galasko</surname><given-names>D</given-names></name><name><surname>Bennett</surname><given-names>D</given-names></name><name><surname>Sano</surname><given-names>M</given-names></name><name><surname>Ernesto</surname><given-names>C</given-names></name><name><surname>Thomas</surname><given-names>R</given-names></name><name><surname>Grundman</surname><given-names>M</given-names></name><name><surname>Ferris</surname><given-names>S</given-names></name></person-group><article-title>An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study</article-title><source>Alzheimer Dis Assoc Disord</source><year>1997</year><volume>11</volume><issue>suppl 2</issue><fpage>S33</fpage><lpage>S39</lpage><pub-id pub-id-type='pmid'>9236950</pub-id></element-citation></ref><ref id='B5'><label>5</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Green</surname><given-names>CR</given-names></name><name><surname>Marin</surname><given-names>DB</given-names></name><name><surname>Mohs</surname><given-names>RC</given-names></name><name><surname>Schmeidler</surname><given-names>J</given-names></name><name><surname>Aryan</surname><given-names>M</given-names></name><name><surname>Fine</surname><given-names>E</given-names></name><name><surname>Davis</surname><given-names>KL</given-names></name></person-group><article-title>The impact of behavioral impairment of functional ability in Alzheimer's disease</article-title><source>Int J Geriatr Psychiatry</source><year>1999</year><volume>14</volume><fpage>307</fpage><lpage>316</lpage><pub-id pub-id-type='pmid'>10340193</pub-id></element-citation></ref><ref id='B6'><label>6</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Harwood</surname><given-names>DG</given-names></name><name><surname>Barker</surname><given-names>WW</given-names></name><name><surname>Ownby</surname><given-names>RL</given-names></name><name><surname>Duara</surname><given-names>R</given-names></name></person-group><article-title>Relationship of behavioral and psychological symptoms to cognitive impairment and functional status in Alzheimer's disease</article-title><source>Int J Geriatr Psychiatry</source><year>2000</year><volume>15</volume><fpage>393</fpage><lpage>400</lpage><pub-id pub-id-type='pmid'>10822237</pub-id></element-citation></ref><ref id='B7'><label>7</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Tekin</surname><given-names>S</given-names></name><name><surname>Fairbanks</surname><given-names>LA</given-names></name><name><surname>O'Connor</surname><given-names>S</given-names></name><name><surname>Rosenberg</surname><given-names>S</given-names></name><name><surname>Cummings</surname><given-names>JL</given-names></name></person-group><article-title>Activities of daily living in Alzheimer's disease: neuropsychiatric, cognitive, and medical illness influences</article-title><source>Am J Geriatr Psychiatry</source><year>2001</year><volume>9</volume><fpage>81</fpage><lpage>86</lpage><pub-id pub-id-type='pmid'>11156757</pub-id></element-citation></ref><ref id='B8'><label>8</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Bouwens</surname><given-names>SF</given-names></name><name><surname>van Heugten</surname><given-names>CM</given-names></name><name><surname>Verhey</surname><given-names>FR</given-names></name></person-group><article-title>Association between cognition and daily life functioning in dementia subtypes</article-title><source>Int J Geriatr Psychiatry</source><year>2009</year><volume>24</volume><fpage>764</fpage><lpage>769</lpage><pub-id pub-id-type='pmid'>19156699</pub-id></element-citation></ref><ref id='B9'><label>9</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Tractenberg</surname><given-names>RE</given-names></name><name><surname>Weiner</surname><given-names>MF</given-names></name><name><surname>Cummings</surname><given-names>JL</given-names></name><name><surname>Patterson</surname><given-names>MB</given-names></name><name><surname>Thal</surname><given-names>LJ</given-names></name></person-group><article-title>Independence of changes in behavior from cognition and function in community-dwelling persons with Alzheimer's disease: a factor analytic approach</article-title><source>J Neuropsychiatry Clin Neurosci</source><year>2005</year><volume>17</volume><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type='pmid'>15746483</pub-id></element-citation></ref><ref id='B10'><label>10</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Lam</surname><given-names>LC</given-names></name><name><surname>Leung</surname><given-names>T</given-names></name><name><surname>Lui</surname><given-names>VW</given-names></name><name><surname>Leung</surname><given-names>VP</given-names></name><name><surname>Chiu</surname><given-names>HF</given-names></name></person-group><article-title>Association between cognitive function, behavioral syndromes and two-year clinical outcome in Chinese subjects with late-onset Alzheimer's disease</article-title><source>Int Psychogeriatr</source><year>2006</year><volume>18</volume><fpage>517</fpage><lpage>526</lpage><pub-id pub-id-type='pmid'>16466588</pub-id></element-citation></ref><ref id='B11'><label>11</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Peters</surname><given-names>KR</given-names></name><name><surname>Rockwood</surname><given-names>K</given-names></name><name><surname>Black</surname><given-names>SE</given-names></name><name><surname>Bouchard</surname><given-names>R</given-names></name><name><surname>Gauthier</surname><given-names>S</given-names></name><name><surname>Hogan</surname><given-names>D</given-names></name><name><surname>Kertesz</surname><given-names>A</given-names></name><name><surname>Loy-English</surname><given-names>I</given-names></name><name><surname>Beattie</surname><given-names>BL</given-names></name><name><surname>Sadovnick</surname><given-names>AD</given-names></name><name><surname>Feldman</surname><given-names>HH</given-names></name></person-group><article-title>Characterizing neuropsychiatric symptoms in subjects referred to dementia clinics</article-title><source>Neurology</source><year>2006</year><volume>66</volume><fpage>523</fpage><lpage>528</lpage><pub-id pub-id-type='pmid'>16505306</pub-id></element-citation></ref><ref id='B12'><label>12</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Starr</surname><given-names>JM</given-names></name><name><surname>Lonie</surname><given-names>J</given-names></name></person-group><article-title>Relationship between behavioural and psychological symptoms of dementia and cognition in Alzheimer's disease</article-title><source>Dement Geriatr Cogn Disord</source><year>2007</year><volume>24</volume><fpage>343</fpage><lpage>347</lpage><pub-id pub-id-type='pmid'>17890863</pub-id></element-citation></ref><ref id='B13'><label>13</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Okura</surname><given-names>T</given-names></name><name><surname>Plassman</surname><given-names>BL</given-names></name><name><surname>Steffens</surname><given-names>DC</given-names></name><name><surname>Llewellyn</surname><given-names>DJ</given-names></name><name><surname>Potter</surname><given-names>GG</given-names></name><name><surname>Langa</surname><given-names>KM</given-names></name></person-group><article-title>Prevalence of neuropsychiatric symptoms and their association with functional limitations in older adults in the United States: the aging, demographics, and memory study</article-title><source>J Am Geriatr Soc</source><year>2010</year><volume>58</volume><fpage>330</fpage><lpage>337</lpage><pub-id pub-id-type='pmid'>20374406</pub-id></element-citation></ref><ref id='B14'><label>14</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Steinberg</surname><given-names>M</given-names></name><name><surname>Shao</surname><given-names>H</given-names></name><name><surname>Zandi</surname><given-names>P</given-names></name><name><surname>Lyketsos</surname><given-names>CG</given-names></name><name><surname>Welsh-Bohmer</surname><given-names>KA</given-names></name><name><surname>Norton</surname><given-names>MC</given-names></name><name><surname>Breitner</surname><given-names>JC</given-names></name><name><surname>Steffens</surname><given-names>DC</given-names></name><name><surname>Tschanz</surname><given-names>JT</given-names></name><collab>Cache County Investigators</collab></person-group><article-title>Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study</article-title><source>Int J Geriatr Psychiatry</source><year>2008</year><volume>23</volume><fpage>170</fpage><lpage>177</lpage><pub-id pub-id-type='pmid'>17607801</pub-id></element-citation></ref><ref id='B15'><label>15</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Yener</surname><given-names>GG</given-names></name><collab>Turkuaz Alzheimer Working (TAC) Group</collab></person-group><article-title>The neuropsychiatric inventory scores changes across the Mini Mental State Examination ranges in patients with Alzheimer's disease: a multicenter study in Turkey</article-title><source>Cogn Behav Neurol</source><year>2009</year><volume>22</volume><fpage>264</fpage><lpage>269</lpage><pub-id pub-id-type='pmid'>19996880</pub-id></element-citation></ref><ref id='B16'><label>16</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Morris</surname><given-names>JC</given-names></name><name><surname>Heyman</surname><given-names>A</given-names></name><name><surname>Mohs</surname><given-names>RC</given-names></name><name><surname>Hughes</surname><given-names>JP</given-names></name><name><surname>van Belle</surname><given-names>G</given-names></name><name><surname>Fillenbaum</surname><given-names>G</given-names></name><name><surname>Mellits</surname><given-names>ED</given-names></name><name><surname>Clark</surname><given-names>C</given-names></name></person-group><article-title>The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease</article-title><source>Neurology</source><year>1989</year><volume>39</volume><fpage>1159</fpage><lpage>1165</lpage><pub-id pub-id-type='pmid'>2771064</pub-id></element-citation></ref><ref id='B17'><label>17</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Welsh</surname><given-names>KA</given-names></name><name><surname>Butters</surname><given-names>N</given-names></name><name><surname>Mohs</surname><given-names>RC</given-names></name><name><surname>Beekly</surname><given-names>D</given-names></name><name><surname>Edland</surname><given-names>S</given-names></name><name><surname>Fillenbaum</surname><given-names>G</given-names></name><name><surname>Heyman</surname><given-names>A</given-names></name></person-group><article-title>The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery</article-title><source>Neurology</source><year>1994</year><volume>44</volume><fpage>609</fpage><lpage>614</lpage><pub-id pub-id-type='pmid'>8164812</pub-id></element-citation></ref><ref id='B18'><label>18</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Hänninen</surname><given-names>T</given-names></name><name><surname>Pulliainen</surname><given-names>V</given-names></name><name><surname>Salo</surname><given-names>J</given-names></name><name><surname>Hokkanen</surname><given-names>L</given-names></name><name><surname>Erkinjuntti</surname><given-names>T</given-names></name><name><surname>Koivisto</surname><given-names>K</given-names></name><name><surname>Viramo</surname><given-names>P</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name></person-group><article-title>Cognitive tests in diagnosing memory disorders and early dementia: CERAD-neuropsychological battery (in Finnish)</article-title><source>Suom Lääkäril</source><year>1999</year><volume>54</volume><fpage>1967</fpage><lpage>1975</lpage></element-citation></ref><ref id='B19'><label>19</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Chandler</surname><given-names>MJ</given-names></name><name><surname>Lacritz</surname><given-names>LH</given-names></name><name><surname>Hynan</surname><given-names>LS</given-names></name><name><surname>Barnard</surname><given-names>HD</given-names></name><name><surname>Allen</surname><given-names>G</given-names></name><name><surname>Deschner</surname><given-names>M</given-names></name><name><surname>Weiner</surname><given-names>MF</given-names></name><name><surname>Cullum</surname><given-names>CM</given-names></name></person-group><article-title>A total score for the CERAD neuropsychological battery</article-title><source>Neurology</source><year>2005</year><volume>65</volume><fpage>102</fpage><lpage>106</lpage><pub-id pub-id-type='pmid'>16009893</pub-id></element-citation></ref><ref id='B20'><label>20</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Paajanen</surname><given-names>T</given-names></name><name><surname>Hänninen</surname><given-names>T</given-names></name><name><surname>Tunnard</surname><given-names>C</given-names></name><name><surname>Mecocci</surname><given-names>P</given-names></name><name><surname>Sobow</surname><given-names>T</given-names></name><name><surname>Tsolaki</surname><given-names>M</given-names></name><name><surname>Vellas</surname><given-names>B</given-names></name><name><surname>Lovestone</surname><given-names>S</given-names></name><name><surname>Soininen</surname><given-names>H</given-names></name><collab>Addneuromed Consortium</collab></person-group><article-title>CERAD neuropsychological battery total score in multinational mild cognitive impairment and control populations: the AddNeuroMed study</article-title><source>J Alzheimers Dis</source><year>2010</year><volume>22</volume><fpage>1089</fpage><lpage>1097</lpage><pub-id pub-id-type='pmid'>20930314</pub-id></element-citation></ref><ref id='B21'><label>21</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Rossetti</surname><given-names>HC</given-names></name><name><surname>Munro Cullum</surname><given-names>C</given-names></name><name><surname>Hynan</surname><given-names>LS</given-names></name><name><surname>Lacritz</surname><given-names>LH</given-names></name></person-group><article-title>The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease</article-title><source>Alzheimer Dis Assoc Disord</source><year>2010</year><volume>24</volume><fpage>138</fpage><lpage>142</lpage><pub-id pub-id-type='pmid'>20505431</pub-id></element-citation></ref><ref id='B22'><label>22</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Seo</surname><given-names>EH</given-names></name><name><surname>Lee</surname><given-names>DY</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Choo</surname><given-names>IH</given-names></name><name><surname>Kim</surname><given-names>JW</given-names></name><name><surname>Kim</surname><given-names>SG</given-names></name><name><surname>Park</surname><given-names>SY</given-names></name><name><surname>Shin</surname><given-names>JH</given-names></name><name><surname>Do</surname><given-names>YJ</given-names></name><name><surname>Yoon</surname><given-names>JC</given-names></name><name><surname>Jhoo</surname><given-names>JH</given-names></name><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Woo</surname><given-names>JI</given-names></name></person-group><article-title>Total scores of the CERAD neuropsychological assessment battery: validation for mild cognitive impairment and dementia patients with diverse etiologies</article-title><source>Am J Geriatr Psychiatry</source><year>2010</year><volume>18</volume><fpage>801</fpage><lpage>809</lpage><pub-id pub-id-type='pmid'>20220577</pub-id></element-citation></ref><ref id='B23'><label>23</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Folstein</surname><given-names>MF</given-names></name><name><surname>Folstein</surname><given-names>SE</given-names></name><name><surname>McHugh</surname><given-names>PR</given-names></name></person-group><article-title>‘Mini-mental state’. A practical method for grading the cognitive state of patients for the clinician</article-title><source>J Psychiatr Res</source><year>1975</year><volume>12</volume><fpage>189</fpage><lpage>198</lpage><pub-id pub-id-type='pmid'>1202204</pub-id></element-citation></ref><ref id='B24'><label>24</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Ashford</surname><given-names>JW</given-names></name></person-group><article-title>Screening for memory disorders, dementia and Alzheimer's disease</article-title><source>Aging Health</source><year>2008</year><volume>4</volume><fpage>399</fpage><lpage>432</lpage></element-citation></ref><ref id='B25'><label>25</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Mitchell</surname><given-names>AJ</given-names></name></person-group><article-title>A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment</article-title><source>J Psychiatr Res</source><year>2009</year><volume>43</volume><fpage>411</fpage><lpage>431</lpage><pub-id pub-id-type='pmid'>18579155</pub-id></element-citation></ref><ref id='B26'><label>26</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Clark</surname><given-names>CM</given-names></name><name><surname>Sheppard</surname><given-names>L</given-names></name><name><surname>Fillenbaum</surname><given-names>GG</given-names></name><name><surname>Galasko</surname><given-names>D</given-names></name><name><surname>Morris</surname><given-names>JC</given-names></name><name><surname>Koss</surname><given-names>E</given-names></name><name><surname>Mohs</surname><given-names>R</given-names></name><name><surname>Heyman</surname><given-names>A</given-names></name></person-group><article-title>Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease</article-title><source>Arch Neurol</source><year>1999</year><volume>56</volume><fpage>857</fpage><lpage>862</lpage><pub-id pub-id-type='pmid'>10404988</pub-id></element-citation></ref><ref id='B27'><label>27</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>McKhann</surname><given-names>G</given-names></name><name><surname>Drachman</surname><given-names>D</given-names></name><name><surname>Folstein</surname><given-names>M</given-names></name><name><surname>Katzman</surname><given-names>R</given-names></name><name><surname>Price</surname><given-names>D</given-names></name><name><surname>Stadlan</surname><given-names>EM</given-names></name></person-group><article-title>Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease</article-title><source>Neurology</source><year>1984</year><volume>34</volume><fpage>939</fpage><lpage>944</lpage><pub-id pub-id-type='pmid'>6610841</pub-id></element-citation></ref><ref id='B28'><label>28</label><element-citation publication-type='book'><person-group person-group-type='author'><name><surname>Pulliainen</surname><given-names>V</given-names></name><name><surname>Hokkanen</surname><given-names>L</given-names></name><name><surname>Salo</surname><given-names>J</given-names></name><name><surname>Hänninen</surname><given-names>T</given-names></name></person-group><article-title>CERAD-kognitiivinen tehtäväsarja. Käsikirja</article-title><source>Manual of the Finnish version of the CERAD neuropsychological battery</source><year>1999</year><publisher-loc>Kuopio</publisher-loc><publisher-name>Suomen Alzheimertutkimusseurary</publisher-name></element-citation></ref><ref id='B29'><label>29</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Morris</surname><given-names>JC</given-names></name></person-group><article-title>The Clinical Dementia Rating (CDR): current version and scoring rules</article-title><source>Neurology</source><year>1993</year><volume>43</volume><fpage>2412</fpage><lpage>2414</lpage><pub-id pub-id-type='pmid'>8232972</pub-id></element-citation></ref><ref id='B30'><label>30</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Hughes</surname><given-names>CP</given-names></name><name><surname>Berg</surname><given-names>L</given-names></name><name><surname>Danziger</surname><given-names>WL</given-names></name><name><surname>Coben</surname><given-names>LA</given-names></name><name><surname>Martin</surname><given-names>RL</given-names></name></person-group><article-title>A new clinical scale for the staging of dementia</article-title><source>Br J Psychiatry</source><year>1982</year><volume>140</volume><fpage>566</fpage><lpage>572</lpage><pub-id pub-id-type='pmid'>7104545</pub-id></element-citation></ref><ref id='B31'><label>31</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Cummings</surname><given-names>JL</given-names></name><name><surname>Mega</surname><given-names>M</given-names></name><name><surname>Gray</surname><given-names>K</given-names></name><name><surname>Rosenberg-Thompson</surname><given-names>S</given-names></name><name><surname>Carusi</surname><given-names>DA</given-names></name><name><surname>Gornbein</surname><given-names>J</given-names></name></person-group><article-title>The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia</article-title><source>Neurology</source><year>1994</year><volume>44</volume><fpage>2308</fpage><lpage>2314</lpage><pub-id pub-id-type='pmid'>7991117</pub-id></element-citation></ref><ref id='B32'><label>32</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Ganguli</surname><given-names>M</given-names></name><name><surname>Ratcliff</surname><given-names>G</given-names></name><name><surname>Huff</surname><given-names>FJ</given-names></name><name><surname>Belle</surname><given-names>S</given-names></name><name><surname>Kancel</surname><given-names>MJ</given-names></name><name><surname>Fischer</surname><given-names>L</given-names></name><name><surname>Seaberg</surname><given-names>EC</given-names></name><name><surname>Kuller</surname><given-names>LH</given-names></name></person-group><article-title>Effects of age, gender, and education on cognitive tests in a rural elderly community sample: norms from the Monongahela Valley Independent Elders Survey</article-title><source>Neuroepidemiology</source><year>1991</year><volume>10</volume><fpage>42</fpage><lpage>52</lpage><pub-id pub-id-type='pmid'>2062416</pub-id></element-citation></ref><ref id='B33'><label>33</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Karrasch</surname><given-names>M</given-names></name><name><surname>Laine</surname><given-names>M</given-names></name></person-group><article-title>Age, education and test performance on the Finnish CERAD</article-title><source>Acta Neurol Scand</source><year>2003</year><volume>108</volume><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type='pmid'>12859285</pub-id></element-citation></ref><ref id='B34'><label>34</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Beeri</surname><given-names>MS</given-names></name><name><surname>Schmeidler</surname><given-names>J</given-names></name><name><surname>Sano</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Lally</surname><given-names>R</given-names></name><name><surname>Grossman</surname><given-names>H</given-names></name><name><surname>Silverman</surname><given-names>JM</given-names></name></person-group><article-title>Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old</article-title><source>Neurology</source><year>2006</year><volume>67</volume><fpage>1006</fpage><lpage>1010</lpage><pub-id pub-id-type='pmid'>17000969</pub-id></element-citation></ref><ref id='B35'><label>35</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Sosa</surname><given-names>AL</given-names></name><name><surname>Albanese</surname><given-names>E</given-names></name><name><surname>Prince</surname><given-names>M</given-names></name><name><surname>Acosta</surname><given-names>D</given-names></name><name><surname>Ferri</surname><given-names>CP</given-names></name><name><surname>Guerra</surname><given-names>M</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Jacob</surname><given-names>KS</given-names></name><name><surname>de Rodriguez</surname><given-names>JL</given-names></name><name><surname>Salas</surname><given-names>A</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Gaona</surname><given-names>C</given-names></name><name><surname>Joteeshwaran</surname><given-names>A</given-names></name><name><surname>Rodriguez</surname><given-names>G</given-names></name><name><surname>de la Torre</surname><given-names>GR</given-names></name><name><surname>Williams</surname><given-names>JD</given-names></name><name><surname>Stewart</surname><given-names>R</given-names></name></person-group><article-title>Population normative data for the 10/66 Dementia Research Group cognitive test battery from Latin America, India and China: a cross-sectional survey</article-title><source>BMC Neurol</source><year>2009</year><volume>9</volume><fpage>48</fpage><pub-id pub-id-type='pmid'>19709405</pub-id></element-citation></ref><ref id='B36'><label>36</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Kavanagh</surname><given-names>S</given-names></name><name><surname>Gaudig</surname><given-names>M</given-names></name><name><surname>Van Baelen</surname><given-names>B</given-names></name><name><surname>Adami</surname><given-names>M</given-names></name><name><surname>Delgado</surname><given-names>A</given-names></name><name><surname>Guzman</surname><given-names>C</given-names></name><name><surname>Jedenius</surname><given-names>E</given-names></name><name><surname>Schauble</surname><given-names>B</given-names></name></person-group><article-title>Galantamine and behavior in Alzheimer's disease: analysis of four trials</article-title><source>Acta Neurol Scand</source><year>2011</year><volume>124</volume><fpage>302</fpage><lpage>308</lpage><pub-id pub-id-type='pmid'>21615354</pub-id></element-citation></ref><ref id='B37'><label>37</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Teng</surname><given-names>E</given-names></name><name><surname>Lu</surname><given-names>PH</given-names></name><name><surname>Cummings</surname><given-names>JL</given-names></name></person-group><article-title>Neuropsychiatric symptoms are associated with progression from mild cognitive impairment to Alzheimer's disease</article-title><source>Dement Geriatr Cogn Disord</source><year>2007</year><volume>24</volume><fpage>253</fpage><lpage>259</lpage><pub-id pub-id-type='pmid'>17700021</pub-id></element-citation></ref><ref id='B38'><label>38</label><element-citation publication-type='journal'><person-group person-group-type='author'><name><surname>Andersen</surname><given-names>F</given-names></name><name><surname>Engstad</surname><given-names>TA</given-names></name><name><surname>Straume</surname><given-names>B</given-names></name><name><surname>Viitanen</surname><given-names>M</given-names></name><name><surname>Halvorsen</surname><given-names>DS</given-names></name><name><surname>Hykkerud</surname><given-names>S</given-names></name><name><surname>Sjøbrend</surname><given-names>K</given-names></name></person-group><article-title>Recruitment methods in Alzheimer's disease research: general practice versus population based screening by mail</article-title><source>BMC Med Res Methodol</source><year>2010</year><volume>10</volume><fpage>35</fpage><pub-id pub-id-type='pmid'>20429946</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap orientation='portrait' id='T1' position='float'><label>Table 1</label><caption><p>Demographic and clinical characteristics of the AD patients participating in the study</p></caption><table rules='groups' frame='hsides'><thead><tr valign='top'><th colspan='1' rowspan='1' align='left'>CDR 0.5</th><th colspan='1' rowspan='1' align='left'>CDR 1</th><th colspan='1' rowspan='1' align='left'>All</th><th colspan='1' rowspan='1' align='left'>p value<xref rid='T1F1' ref-type='table-fn'><sup>*</sup></xref></th></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1'></td></tr><tr valign='top'><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1' align='left'>(n = 80)</td><td colspan='1' rowspan='1' align='left'>(n = 156)</td><td colspan='1' rowspan='1' align='left'>(n = 236)</td><td colspan='1' rowspan='1'></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Female, %</td><td colspan='1' rowspan='1' align='left'>53.8</td><td colspan='1' rowspan='1' align='left'>50</td><td colspan='1' rowspan='1' align='left'>51.3</td><td colspan='1' rowspan='1'></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Age, years</td><td colspan='1' rowspan='1' align='left'>73.85 ± 6.95</td><td colspan='1' rowspan='1' align='left'>75.75 ± 6 26</td><td colspan='1' rowspan='1' align='left'>75.11 ± 6.55</td><td colspan='1' rowspan='1' align='left'>0.245</td></tr><tr valign='top'><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1' align='left'>(56–87)</td><td colspan='1' rowspan='1' align='left'>(53–90)</td><td colspan='1' rowspan='1' align='left'>(53–90)</td><td colspan='1' rowspan='1'></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Education, years</td><td colspan='1' rowspan='1' align='left'>8.14 ± 3.32</td><td colspan='1' rowspan='1' align='left'>7.25 ± 3.25</td><td colspan='1' rowspan='1' align='left'>7.55 ± 3.29</td><td colspan='1' rowspan='1' align='left'>0.350</td></tr><tr valign='top'><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1' align='left'>(1–18)</td><td colspan='1' rowspan='1' align='left'>(1–20)</td><td colspan='1' rowspan='1' align='left'>(1–20)</td><td colspan='1' rowspan='1'></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>CERAD total score<xref rid='T1F2' ref-type='table-fn'><sup>1</sup></xref> (scale 0–100)</td><td colspan='1' rowspan='1' align='left'>56.09 ±12.63</td><td colspan='1' rowspan='1' align='left'>49.28 ± 10.77</td><td colspan='1' rowspan='1' align='left'>51.58 ± 11.85</td><td colspan='1' rowspan='1' align='left'>&lt;0.001</td></tr><tr valign='top'><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1' align='left'>(25–96)</td><td colspan='1' rowspan='1' align='left'>(22–82)</td><td colspan='1' rowspan='1' align='left'>(22–96)</td><td colspan='1' rowspan='1'></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>MMSE score (scale 0–30)</td><td colspan='1' rowspan='1' align='left'>23.22 ± 2.95</td><td colspan='1' rowspan='1' align='left'>20.62 ± 3.34</td><td colspan='1' rowspan='1' align='left'>21.5 ± 3.44</td><td colspan='1' rowspan='1' align='left'>&lt;0.001</td></tr><tr valign='top'><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1' align='left'>(16–30)</td><td colspan='1' rowspan='1' align='left'>(12–30)</td><td colspan='1' rowspan='1' align='left'>(12–30)</td><td colspan='1' rowspan='1'></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>CDR–SOB score (scale 0–18)</td><td colspan='1' rowspan='1' align='left'>2.60 ± 0.70</td><td colspan='1' rowspan='1' align='left'>4.91 ± 1.13</td><td colspan='1' rowspan='1' align='left'>4.13 ± 1.49</td><td colspan='1' rowspan='1' align='left'>&lt;0.001</td></tr><tr valign='top'><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1' align='left'>(1–3.5)</td><td colspan='1' rowspan='1' align='left'>(3–8)</td><td colspan='1' rowspan='1' align='left'>(1–8)</td><td colspan='1' rowspan='1'></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>ADCS-ADL score (scale 0–78)</td><td colspan='1' rowspan='1' align='left'>69.63 ± 5.99</td><td colspan='1' rowspan='1' align='left'>61.91 ± 8.78</td><td colspan='1' rowspan='1' align='left'>64.53 ± 8.73</td><td colspan='1' rowspan='1' align='left'>&lt;0.001</td></tr><tr valign='top'><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1' align='left'>(50–78)</td><td colspan='1' rowspan='1' align='left'>(34–76)</td><td colspan='1' rowspan='1' align='left'>(34–78)</td><td colspan='1' rowspan='1'></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>NPI score (0–144)</td><td colspan='1' rowspan='1' align='left'>6.31 ± 7.25</td><td colspan='1' rowspan='1' align='left'>10.16 ± 10.63</td><td colspan='1' rowspan='1' align='left'>8.86 ± 9.78</td><td colspan='1' rowspan='1' align='left'>0.028</td></tr><tr valign='top'><td colspan='1' rowspan='1'></td><td colspan='1' rowspan='1' align='left'>(0–32)</td><td colspan='1' rowspan='1' align='left'>(0–49)</td><td colspan='1' rowspan='1' align='left'>(0–49)</td><td colspan='1' rowspan='1'></td></tr></tbody></table><table-wrap-foot><fn><p>Values are mean ± SD with ranges in parentheses, unless indicated otherwise.</p></fn><fn id='T1F1'><label>*</label><p>Pairwise comparisons of the difference between very mild (CDR = 0.5) and mild (CDR = 1) AD dementia, significance of difference in two-tailed t test or Mann-Whitney U test, calculated by Bonferroni correction.</p></fn><fn id='T1F2'><label>1</label><p>n = 234.</p></fn></table-wrap-foot></table-wrap><table-wrap orientation='portrait' id='T2' position='float'><label>Table 2</label><caption><p>Correlations between demographic and clinical characteristics of the AD patients participating in the study</p></caption><table rules='groups' frame='hsides'><thead><tr valign='top'><td colspan='1' rowspan='1' align='left'></td><td colspan='1' rowspan='1' align='left'>CERAD</td><td colspan='1' rowspan='1' align='left'>MMSE</td><td colspan='1' rowspan='1' align='left'>CDR–SOB</td><td colspan='1' rowspan='1' align='left'>ADCS–ADL</td><td colspan='1' rowspan='1' align='left'>NPI</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'></td><td colspan='1' rowspan='1' align='left'>total score<xref rid='T2F3' ref-type='table-fn'><sup>†</sup></xref></td><td colspan='1' rowspan='1' align='left'>score<xref rid='T2F3' ref-type='table-fn'><sup>†</sup></xref></td><td colspan='1' rowspan='1' align='left'>score<xref rid='T2F3' ref-type='table-fn'><sup>†</sup></xref></td><td colspan='1' rowspan='1' align='left'>score<xref rid='T2F4' ref-type='table-fn'><sup>‡</sup></xref></td><td colspan='1' rowspan='1' align='left'>score<xref rid='T2F4' ref-type='table-fn'><sup>‡</sup></xref></td></tr><tr valign='top'><td colspan='6' rowspan='1' align='left'><hr></hr></td></tr></thead><tbody><tr valign='top'><td colspan='1' rowspan='1' align='left'>Education (years)</td><td colspan='1' rowspan='1' align='left'>0.334<xref rid='T2F1' ref-type='table-fn'><sup>***</sup></xref></td><td colspan='1' rowspan='1' align='left'>0.278<xref rid='T2F1' ref-type='table-fn'><sup>***</sup></xref></td><td colspan='1' rowspan='1' align='left'>–0.204<xref rid='T2F2' ref-type='table-fn'><sup>*</sup></xref></td><td colspan='1' rowspan='1' align='left'>0.357<xref rid='T2F1' ref-type='table-fn'><sup>***</sup></xref></td><td colspan='1' rowspan='1' align='left'>–0.092</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>Age (years)</td><td colspan='1' rowspan='1' align='left'>0.062</td><td colspan='1' rowspan='1' align='left'>0.035</td><td colspan='1' rowspan='1' align='left'>0.159</td><td colspan='1' rowspan='1' align='left'>–0.201<xref rid='T2F2' ref-type='table-fn'><sup>*</sup></xref></td><td colspan='1' rowspan='1' align='left'>–0.073</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>CERAD total score</td><td colspan='1' rowspan='1' align='left'></td><td colspan='1' rowspan='1' align='left'>0.618<xref rid='T2F1' ref-type='table-fn'><sup>***</sup></xref></td><td colspan='1' rowspan='1' align='left'>–0.319<xref rid='T2F1' ref-type='table-fn'><sup>***</sup></xref></td><td colspan='1' rowspan='1' align='left'>0.250<xref rid='T2F1' ref-type='table-fn'><sup>***</sup></xref></td><td colspan='1' rowspan='1' align='left'>–0.087</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>MMSE score</td><td colspan='1' rowspan='1' align='left'></td><td colspan='1' rowspan='1' align='left'></td><td colspan='1' rowspan='1' align='left'>–0.443<xref rid='T2F1' ref-type='table-fn'><sup>***</sup></xref></td><td colspan='1' rowspan='1' align='left'>0.314<xref rid='T2F1' ref-type='table-fn'><sup>***</sup></xref></td><td colspan='1' rowspan='1' align='left'>0.049</td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>CDR-SOB score</td><td colspan='1' rowspan='1' align='left'></td><td colspan='1' rowspan='1' align='left'></td><td colspan='1' rowspan='1' align='left'></td><td colspan='1' rowspan='1' align='left'>–0.580<xref rid='T2F1' ref-type='table-fn'><sup>***</sup></xref></td><td colspan='1' rowspan='1' align='left'>0.231<xref rid='T2F1' ref-type='table-fn'><sup>***</sup></xref></td></tr><tr valign='top'><td colspan='1' rowspan='1' align='left'>ADCS-ADL score</td><td colspan='1' rowspan='1' align='left'></td><td colspan='1' rowspan='1' align='left'></td><td colspan='1' rowspan='1' align='left'></td><td colspan='1' rowspan='1' align='left'></td><td colspan='1' rowspan='1' align='left'>–0.339<xref rid='T2F1' ref-type='table-fn'><sup>***</sup></xref></td></tr><tr valign='top'><td colspan='6' rowspan='1' align='left'><hr></hr></td></tr></tbody></table><table-wrap-foot><fn id='T2F1'><label>***</label><p>p &lt; 0.001,</p></fn><fn id='T2F2'><label>*</label><p>p &lt; 0.05, calculated by Bonferroni correction.</p></fn><fn id='T2F3'><label>†</label><p>Pearson's product-moment correlation coefficient;</p></fn><fn id='T2F4'><label>‡</label><p>Spearman's rank correlation coefficient.</p></fn></table-wrap-foot></table-wrap></floats-group></article></PAPER>